These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4436518)

  • 1. Providing quality drugs economically. The role of state formularies.
    Meyer MC; Bates H; Swift RG
    J Am Pharm Assoc; 1974 Dec; 14(12):663-6. PubMed ID: 4436518
    [No Abstract]   [Full Text] [Related]  

  • 2. [The physician, the pharmacist and magistral preparations].
    Scholten WK; Tel H
    Ned Tijdschr Geneeskd; 1991 May; 135(20):885-9. PubMed ID: 2046789
    [No Abstract]   [Full Text] [Related]  

  • 3. The economic and human impact of new drugs.
    Lichtenberg FR
    J Clin Psychiatry; 2003; 64 Suppl 17():15-8. PubMed ID: 14680422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferred drug lists for Medicaid.
    Kozma CM
    Manag Care Interface; 2003 Jun; 16(6):47-8. PubMed ID: 12841075
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality drugs and the Saskatchewan formulary.
    Johnson GE
    Can J Hosp Pharm; 1975; 28(3):84-6. PubMed ID: 10316621
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of formularies on clinical innovation.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 17():11-4. PubMed ID: 14680421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic formularies, essential drugs, drug utilization studies.
    Tognoni G; Lunde PK
    WHO Reg Publ Eur Ser; 1993; 45():43-53. PubMed ID: 8442849
    [No Abstract]   [Full Text] [Related]  

  • 8. The case for "dispense as written".
    Weston JK
    Va Med; 1979 Mar; 106(3):198-9. PubMed ID: 442785
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of restrictive formularies in the ambulatory care setting.
    Lexchin J
    Am J Manag Care; 2002 Jan; 8(1):69-76. PubMed ID: 11814174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMOs try formularies in effort to curb prescription costs.
    Feldman A
    Contract Healthc; 1988 Jul; ():33-5. PubMed ID: 10290628
    [No Abstract]   [Full Text] [Related]  

  • 11. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange.
    Burkhart CG
    J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
    Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
    Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of generics is driving up prices of single-source drugs.
    Fine J
    Mod Healthc; 1986 Nov; 16(24):48. PubMed ID: 10279441
    [No Abstract]   [Full Text] [Related]  

  • 16. How effectively do managed care organizations influence prescribing and dispensing decisions?
    Carroll NV
    Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual Albany College of Pharmacy prescription survey.
    DeNuzzo RV
    Med Mark Media; 1979 Apr; 14(4):15-6, 18-20, 22-5 passim. PubMed ID: 10241448
    [No Abstract]   [Full Text] [Related]  

  • 18. New York State and drug lists: a history of confusion.
    Stetler CJ
    Med Mark Media; 1978 Sep; 13(9):36, 38, 40 passim. PubMed ID: 10316687
    [No Abstract]   [Full Text] [Related]  

  • 19. [An overlooked effect: synonyms reduce the price of original drug preparations].
    Gunnarsson B
    Lakartidningen; 1991 Jun; 88(24):2195. PubMed ID: 2056824
    [No Abstract]   [Full Text] [Related]  

  • 20. Rx cost control: what's your role?
    Guglielmo WJ
    Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.